BCL2L11 and neoplasm: miR-192-5p facilitates proliferation by repressing the proapoptotic factor BIM [36]; miR-223-3p enhances tumor growth by directly targeting FBXW7, a tumor suppressor that controls the stability of key cell cycle regulators such as c-MYC and c-Jun [37].